Showing results (1-10 of 559) with videos related to
Sort By:
Pageof 56
Expert Opinion on Drug Safety|November 22, 2013
Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTCNicholas Moore, Francesco Salvo, Mai Duong, et al.Expert Opinion on Drug Safety|May 12, 2017
Methods for safety signal detection in healthcare databases: a literature reviewMickael Arnaud, Bernard Bégaud, Nicolas Thurin, et al.Drug Safety|May 16, 2013
A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in FranceFrancesco Salvo, Florent Leborgne, Frantz Thiessard, et al.Pharmacological Research|August 10, 2016
Pharmacological treatments of cardiovascular diseases: Evidence from real-life studiesFrancesco Salvo, Julien Bezin, Pauline Bosco-Levy, et al.Drug Safety|April 19, 2014
Fibrates and risk of cancer in tissues with high PPAR-α concentration: a nested case-control studyFrancesco Salvo, Fabienne Bazin, Aude Kostrzewa, et al.British Journal of Clinical Pharmacology|October 10, 2013
Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in FranceMai Duong, Francesco Salvo, Antoine Pariente, et al.BMJ (Clinical Research Ed.)|May 5, 2016
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisFrancesco Salvo, Nicholas Moore, Mickael Arnaud, et al.Expert Opinion on Drug Safety|April 5, 2014
Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studiesFrancesco Salvo, Stefania Antoniazzi, Mai Duong, et al.Drug Safety|December 31, 2015
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting DatabasesMickael Arnaud, Francesco Salvo, Ismaïl Ahmed, et al.Drug Safety|November 5, 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in FranceSibylle de Germay, Allison Singier, Francesco Salvo, et al.Pageof 56